GlassScriptPhysician profile
Frank M Bauer
NPI 1902982754
$1,723.70
in general payments reported to CMS, 2019-2025
15 companies · $33.81 in 2025
The $33.81 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $223 · 2021: $610 · 2022: $360 · 2024: $16.94 · 2025: $33.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $50.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $50.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $298.47 | 2019-2025 | Sjm Regent |
| Elutia, INC. | $284.59 | 2019-2022 | |
| Abiomed | $262.61 | 2019-2022 | |
| Atricure, INC. | $231.31 | 2019-2022 | |
| Edwards Lifesciences Corporation | $138.67 | 2021 | |
| Amarin Pharma, INC. | $124.85 | 2019 | |
| Lemaitre Vascular, INC. | $110.12 | 2019-2022 | |
| Ethicon US, LLC | $74.99 | 2019-2020 | |
| Davol INC. | $45.08 | 2021 | |
| Depuy Synthes Sales INC. | $36.77 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.52 | 2024-2025 | Lifevest |
| Smith+Nephew, INC. | $31.79 | 2019 | |
| Silk Road Medical, INC. | $24.12 | 2021-2022 | |
| Medtronic Vascular, INC. | $13.78 | 2020 | |
| Zimmer Biomet Holdings, INC. | $12.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.